Merck to Showcase New Data Across MS Portfolio at EAN 2019 0 24.06.2019 15:00 Tass.com Company to present 16 abstracts on MAVENCLAD® (cladribine tablets), Rebif® ( interferon beta-1a) and investigational evobrutinib at the 5th Congress of the European Academy of Neurology Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
